Skip to main content
Erschienen in: Virology Journal 1/2020

Open Access 01.12.2020 | Case Report

A probable role of copper in the comorbidity in Wilson’s and Creutzfeldt-Jakob’s Diseases: a case report

verfasst von: Effrosyni Koutsouraki, Dimitrios Michmizos, Olga Patsi, John Tzartos, Martha Spilioti, Marianthi Arnaoutoglou, Magda Tsolaki

Erschienen in: Virology Journal | Ausgabe 1/2020

Abstract

Background

To the best of our knowledgedd, there is currently no case in the literature reporting the comorbidity of Wilson’s and Creutzfeldt-Jakob disease (CJD), linked through copper.

Case presentation

A 44-year-old male with a history of inherited Wilson’s disease (hepatolenticular degeneration), which manifested as mild liver injury and psychiatric symptoms, was admitted to our department due to speech and cognitive disturbances. Upon his admission, he had motor aphasia as well as psychomotor retardation with an otherwise normal neurological examination. Laboratory tests, including liver enzymes, copper and serum ammonia were all within normal range. The brain MRI showed increased T2 signal in the caudate nuclei, attributed to copper deposition in the context of Wilson’s disease. In the electroencephalogram, periodic sharp discharges were eminent, initially unilateral and then generalized. The positive 14–3-3 protein in the cerebrospinal fluid (CSF) and the new brain MRI, that demonstrated elevated DWI signal not only in the basal ganglia but also in parts of the cerebral cortex (cortical ribbon sign), all supportive of a possible CJD diagnosis. The detection of PrPSc in the patient’s CSF, using the RT-QuIC method, which has a 99.4–100% specificity for CJD, made the diagnosis of CJD highly probable.

Conclusion

This is the first report of Wilson’s and Creutzfeldt-Jakob diseases co-morbidity in the literature, which could evoke a possible role of copper in the pathogenesis of CJD.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CJD
Creutzfeldt-Jakob disease
CSF
Cerebrospinal fluid
Cu
Copper
DWI
Diffusion-Weighted Image
EEG
Electroencephalogram
ELISA
Enzyme linked immunosorbent assays
FLAIR
Fluid-Attenuated Inversion Recovery
iv
Intravenous
MRI
Magnetic resonance imaging
PCR
Polymerase chain reaction
PrPSc
Scrapie isoform of the prion protein
PrPc
Cellular prion protein: Real-time quaking-induced conversion
PSWC
Periodic sharp wave complexes
RT-QuIC
Real-time quaking-induced conversion
TSEs
Transmissible spongiform encephalopathies

Background

Although the precise function of PrPC in healthy tissues is not yet known, recent research has demonstrated that it binds copper (Cu) in an unusual and highly conserved region of the protein termed the octarepeat domain [1, 2]. A possible synergistic role of the prion protein in the pathologic metabolism of copper occurring in the context of Wilson’s disease has also been suggested [3, 4]. The transmissible spongiform encephalopathies (TSEs) arise from the conversion of the membrane-bound prion protein from PrPc to PrPSc. Examples of the TSEs include mad cow disease, chronic wasting disease in deer and elk, scrapie in goats and sheep, and kuru and Creutzfeldt-Jakob disease (CJD) in humans. Sporadic and inherited prion diseases fall into the same class as Alzheimer’s and Parkinson’s disease, insofar that they are all associated with the accumulation of endogenous protein aggregates [59].
We present a case of co-morbidity of hepatolenticular degeneration (Wilson’s disease) and CJD that suggests a possible association of copper metabolism with the pathogenesis of CJD disease.

Case presentation

A 44-year-old male with a known history of inherited Wilson’s disease (both his brother and father suffered from the same disease), who had mild liver problems for 12 years and bipolar psychosis in the months prior to presenting himself, was admitted to the emergency services of our University neurological department with a month-long progressive episode of aphasia.
The diagnosis of Wilson’s disease was based on the patients’ metabolic profile, the increased urine copper excretion combined with decreased ceruloplasmin plasma levels. Psychiatric symptoms were present from the initial states of the disease. Almost all family members showed agitation or bipolar disorder. Liver pathology relevant to the disease was present in both siblings whereas the father’s liver biopsy was normal. No focal neurological deficit was present at the time diagnosis was established in all three men. PCR testing for the most prevalent ATP78 variants in the Greek population was negative; however, Sanger sequencing analysis was not performed.
Upon his admission to our clinic, he had motor aphasia and psychomotor retardation without any other neurological signs and with a Glasgow Coma Scale score of 13/15 (5-4-4). Laboratory tests, including liver enzymes, copper and serum ammonia were all normal, whereas the brain MRI showed an increased T2 signal in the caudate nuclei attributed to copper deposition in the context of Wilson’s disease (Fig. 1). The EEG revealed slowing and lateralized periodic discharges, slow (< 2.5 Hz) spikes and waves over the left hemisphere (less often involving the right one) with spatiotemporal evolution. These EEG findings raised the suspicion of non-convulsive status epilepticus, thus they were suppressed by iv benzodiazepines but without clinical improvement (Fig. 2) and antiepileptic treatment with iv levetiracetam was initiated.
CSF examination showed normal cell count, glucose and protein levels and there was no intrathecal viral antibody production. The CSF culture was negative while negative was also the search for antibodies to an autoimmune encephalitis antigen panel.
The patient’s clinical condition deteriorated very rapidly. As his aphasia evolved to mutismus, he developed myoclonic jerks and there was gradual worsening of his level of consciousness. Finally, within a few days, the patient demonstrated myoclonic status epilepticus which remained unresponsive to benzodiazepines or other antiepileptic treatment. An empirical treatment with high-dose iv methylprednisolone for 7 days was also administered with no benefit. The rapid cognitive deterioration and the myoclonic status raised the hypothesis of CJD.
A second brain MRI, performed 15 days later, showed increased DWI and T2(FLAIR) signal not only in the basal ganglia but also in the cerebral cortex (cortical ribbon sign), also suggesting CJD [10, 11] (Fig. 3). A second EEG showed periodic sharp wave complexes (PSWC) with predominance over the left frontocentral regions demonstrating the triphasic morphology, typical of CJD (Fig. 4).
Finally, a second CSF examination revealed positive values for all CSF biomarkers tested: protein 14–3-3 (CircuLex ELISA, MBL, Japan), Tau and phosphoTau (Fujirebio/Innotest ELISA) and PrPSc detection by RT-QuIC [12, 13] (Table 1).
Table 1
CSF biomarkers
Test
Result
14–3-3
Positive, 166,000 AU/ml
Tau
1920 pg/ml (> 1150 increases CJD probability)
P-tau
18 pg/ml
Tau/p-Tau ratio
106 (> 17 increases CJD probability)
PrPSc(RT-QulC) [12, 13]
Positive
The clinical picture, the highly positive 14–3-3 protein, Tau and Tau/pTau levels in the CSF and the new brain MRI that demonstrated elevated DWI signal not only in the basal ganglia but also in the cerebral cortex (cortical ribbon sign) all made the diagnosis of CJD possible. The detection of PrPSc in the CSF using the RT-QuIC method, which has been reported to have a 99.4–100% specificity for CJD [12, 13], made the diagnosis of CJD highly probable [14].
The patient kept deteriorating and passed away 2 months after his initial presentation. At the request of the family no autopsy was performed.

Discussion and conclusions

The present case may well be the first report of Wilson’s and Creutzfeldt-Jakob diseases co-morbidity, suggesting a possible association of copper metabolism with the pathogenesis of CJD. Several recent studies investigate the relationship of copper and prion protein and its role in the pathogenesis of the CJD which remains unclear [79]. This case sparks a new clinical interest in pursuing further research in this direction.

Acknowledgements

We are indebted to Drs Alison Green and Neil Mckenzie for invaluable help with setting up the RT-QuIC assay and Dr. Christos Stergiou for technical assistance.
Our study was approved by the Aristotle University School of Medicine Bioethics and Ethics Committee, Thessaloniki, Greece.
During his stay and treatment in our department, the patient signed the standard required statement, confirming his informed consent for our team to present, report and publish his anonymous individual patient data.

Competing interests

JT is a shareholder in the research and diagnostic laboratory Tzartos NeuroDiagnostics. All other authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original s, Journal(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Qin K, Coomaraswamy J, Mastrangelo P, et al. The PrP-like protein Doppel binds copper. J Biol Chem. 2003;14(278):8888–96.CrossRef Qin K, Coomaraswamy J, Mastrangelo P, et al. The PrP-like protein Doppel binds copper. J Biol Chem. 2003;14(278):8888–96.CrossRef
2.
Zurück zum Zitat Aronoff-Spencer E, Burns CS, Avdievich NI, et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 2000;14(39):13760–71.CrossRef Aronoff-Spencer E, Burns CS, Avdievich NI, et al. Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 2000;14(39):13760–71.CrossRef
3.
Zurück zum Zitat Merle U, Stremmel W, Geßner R. Influence of Homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol. 2006;63(7):982–5.CrossRef Merle U, Stremmel W, Geßner R. Influence of Homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol. 2006;63(7):982–5.CrossRef
4.
Zurück zum Zitat Forbes N, Goodwin S, Woodward K, et al. Evidence for synergistic effects of PRNP and ATP7B mutations in severe neuropsychiatric deterioration. BMC Med Genet. 2014;15:22 Published 2014 Feb 20.CrossRef Forbes N, Goodwin S, Woodward K, et al. Evidence for synergistic effects of PRNP and ATP7B mutations in severe neuropsychiatric deterioration. BMC Med Genet. 2014;15:22 Published 2014 Feb 20.CrossRef
9.
Zurück zum Zitat Evans EG, Millhauser GL. Copper-and Zinc-Promoted Interdomain Structure in the Prion Protein: A Mechanism for Autoinhibition of the Neurotoxic N-Terminus. In: Progress in molecular biology and translational science, vol. 150.: Academic Press; 2017. p. 35–56. Evans EG, Millhauser GL. Copper-and Zinc-Promoted Interdomain Structure in the Prion Protein: A Mechanism for Autoinhibition of the Neurotoxic N-Terminus. In: Progress in molecular biology and translational science, vol. 150.: Academic Press; 2017. p. 35–56.
11.
Zurück zum Zitat Abdulmassih R, Min Z. An ominous radiographic feature: cortical ribbon sign. Intern Emerg Med. 2016;11(2):281–3.CrossRef Abdulmassih R, Min Z. An ominous radiographic feature: cortical ribbon sign. Intern Emerg Med. 2016;11(2):281–3.CrossRef
13.
Zurück zum Zitat Bongianni M, Orrù C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurology. 2017;74(2):155–62.CrossRef Bongianni M, Orrù C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurology. 2017;74(2):155–62.CrossRef
14.
Zurück zum Zitat Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;0:1–8. Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;0:1–8.
Metadaten
Titel
A probable role of copper in the comorbidity in Wilson’s and Creutzfeldt-Jakob’s Diseases: a case report
verfasst von
Effrosyni Koutsouraki
Dimitrios Michmizos
Olga Patsi
John Tzartos
Martha Spilioti
Marianthi Arnaoutoglou
Magda Tsolaki
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2020
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01309-x

Weitere Artikel der Ausgabe 1/2020

Virology Journal 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.